MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load

被引:30
|
作者
Janes, Holly [1 ,2 ]
Frahm, Nicole [1 ,3 ]
DeCamp, Allan [1 ]
Rolland, Morgane [4 ]
Gabriel, Erin [2 ]
Wolfson, Julian [5 ]
Hertz, Tomer [1 ]
Kallas, Esper [6 ]
Goepfert, Paul [7 ]
Friedrich, David P. [1 ]
Corey, Lawrence [1 ,8 ]
Mullins, James I. [9 ]
McElrath, M. Juliana [1 ,8 ]
Gilbert, Peter [1 ,2 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Div Vaccines & Infect Dis, Seattle, WA 98104 USA
[2] Univ Washington, Dept Biostat, Seattle, WA 98195 USA
[3] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA
[4] US Mil HIV Res Program MHRP, Rockville, MD USA
[5] Univ Minnesota, Div Biostat, Minneapolis, MN USA
[6] Univ Sao Paulo, Div Clin Immunol & Allergy, Sao Paulo, Brazil
[7] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA
[8] Univ Washington, Dept Med, Seattle, WA USA
[9] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA
来源
PLOS ONE | 2012年 / 7卷 / 08期
关键词
FALSE DISCOVERY RATE; MEDIATED-IMMUNITY; STEP; GAG; EPITOPES; ESCAPE; CTL;
D O I
10.1371/journal.pone.0043396
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: The sieve analysis for the Step trial found evidence that breakthrough HIV-1 sequences for MRKAd5/HIV-1 Gag/Pol/Nef vaccine recipients were more divergent from the vaccine insert than placebo sequences in regions with predicted epitopes. We linked the viral sequence data with immune response and acute viral load data to explore mechanisms for and consequences of the observed sieve effect. Methods: Ninety-one male participants (37 placebo and 54 vaccine recipients) were included; viral sequences were obtained at the time of HIV-1 diagnosis. T-cell responses were measured 4 weeks post-second vaccination and at the first or second week post-diagnosis. Acute viral load was obtained at RNA-positive and antibody-negative visits. Findings: Vaccine recipients had a greater magnitude of post-infection CD8+ T cell response than placebo recipients (median 1.68% vs 1.18%; p = 0.04) and greater breadth of post-infection response (median 4.5 vs 2; p = 0.06). Viral sequences for vaccine recipients were marginally more divergent from the insert than placebo sequences in regions of Nef targeted by pre-infection immune responses (p = 0.04; Pol p = 0.13; Gag p = 0.89). Magnitude and breadth of pre-infection responses did not correlate with distance of the viral sequence to the insert (p. 0.50). Acute log viral load trended lower in vaccine versus placebo recipients (estimated mean 4.7 vs 5.1) but the difference was not significant (p = 0.27). Neither was acute viral load associated with distance of the viral sequence to the insert (p>0.30). Interpretation: Despite evidence of anamnestic responses, the sieve effect was not well explained by available measures of T-cell immunogenicity. Sequence divergence from the vaccine was not significantly associated with acute viral load. While point estimates suggested weak vaccine suppression of viral load, the result was not significant and more viral load data would be needed to detect suppression.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] HUMAN T-CELL EPITOPES ON HIV-1 - STRATEGIES FOR VACCINE DEVELOPMENT
    ENNIS, FA
    LITTAUA, RA
    TAKAHASHI, K
    WEST, K
    DAI, LC
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 : S42 - S42
  • [22] Impact of HLA-II associated HIV-1 adaptations on vaccine-induced CD4 T-cell immune responses
    Files, J.
    Sterrett, S.
    Fram, T.
    Erdmann, N.
    Bansal, A.
    Goepfert, P.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24
  • [23] Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults
    Priddy, Frances H.
    Brown, Deborah
    Kublin, James
    Monahan, Kathleen
    Wright, David P.
    Lalezari, Jacob
    Santiago, Steven
    Marmor, Michael
    Lally, Michelle
    Novak, Richard M.
    Brown, Stephen J.
    Kulkarni, Priya
    Dubey, Sheri A.
    Kierstead, Lisa S.
    Casimiro, Danilo R.
    Mogg, Robin
    DiNubile, Mark J.
    Shiver, John W.
    Leavitt, Randi Y.
    Robertson, Michael N.
    Mehrotra, Devan V.
    Quirk, Erin
    CLINICAL INFECTIOUS DISEASES, 2008, 46 (11) : 1769 - 1781
  • [24] HLA-II-Associated HIV-1 Adaptation Decreases CD4+ T-Cell Responses in HIV-1 Vaccine Recipients
    Files, Jacob K.
    Sterrett, Sarah
    Henostroza, Sebastian
    Fucile, Christopher
    Maroney, Kevin
    Fram, Tim
    Mallal, Simon
    Kalams, Spyros
    Carlson, Jonathan
    Rosenberg, Alexander
    Erdmann, Nathan
    Bansal, Anju
    Goepfert, Paul A.
    JOURNAL OF VIROLOGY, 2022, 96 (17)
  • [25] Comparison of three lymphoproliferation assays to monitor HIV-specific T-cell responses in vaccinees immunized with HIV-1 DNA vaccine and HIV-1 MVA
    Godoy-Ramirez, K.
    Jernberg, L.
    Karlen, K.
    Edback, U.
    Marovich, M.
    Wahren, B.
    Sandstrom, E.
    Nilsson, C.
    Biberfeld, G.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (10) : A111 - A111
  • [26] HIV-1 Nef and T-cell activation: a history of contradictions
    Markle, Tristan J.
    Mwimanzi, Philip
    Brockman, Mark A.
    FUTURE VIROLOGY, 2013, 8 (04) : 391 - 404
  • [27] HIV-1 infections during vaccine trials: Identifying new epitopes for differential diagnosis of HIV-1 infections in the face of vaccine-induced antibodies
    Golding, Hana
    Needham, James
    Khurana, Surender
    RETROVIROLOGY, 2005, 2 (Suppl 1)
  • [28] CYTOKINES FROM VACCINE-INDUCED HIV-1 SPECIFIC CYTOTOXIC T-LYMPHOCYTES - EFFECTS ON VIRAL REPLICATION
    BOLLINGER, RC
    QUINN, TC
    LIU, AY
    STANHOPE, PE
    HAMMOND, SA
    VIVEEN, R
    CLEMENTS, ML
    SILICIANO, RF
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (11) : 1067 - 1077
  • [29] CLONAL ANALYSIS OF T-CELL RESPONSES TO THE HIV-1 ENVELOPE PROTEINS IN AIDS VACCINE RECIPIENTS
    SILICIANO, RF
    BOLLINGER, RC
    CALLAHAN, KM
    HAMMOND, SA
    LIU, AY
    MISKOVSKY, EP
    ROWELL, JF
    STANHOPE, PE
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (08) : 1349 - 1352
  • [30] Recognition of variant HIV-1 epitopes from diverse viral subtypes by vaccine-induced CTL
    McKinney, DM
    Skvoretz, R
    Livingston, BD
    Wilson, CC
    Anders, M
    Chesnut, RW
    Sette, A
    Essex, M
    Novitsky, V
    Newman, MJ
    JOURNAL OF IMMUNOLOGY, 2004, 173 (03): : 1941 - 1950